Has Peggy Headstrom, MD received payments from drug or device companies?

Yes. Drug and device makers reported $36,055 in general payments to Peggy Headstrom, MD across 163 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Peggy Headstrom, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Peggy Headstrom, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Peggy Headstrom, MD

Gastroenterology · Seattle, WANPI 1962518944

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $28,988 of the $36,055 with a category attached, or 80.4%. 17 manufacturers reported payments, led by Johnson & Johnson at 52.9% of the total. 2025 is the largest year on record at $33,928, more than ten times the $144 reported in 2019. Among gastroenterology clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$36,055in general payments, 2019–2025

Across 163 payments — averaging $221.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$19K
AbbVie$16K
Pfizer$376
Takeda Pharmaceuticals U.S.A., Inc.$254
Sanofi$159
Bristol Myers Squibb$117
plus $560 from 11 others

What the payments were for

Speaking & faculty fees$28,98880%
Travel & lodging$2,7788%
Food & beverage$4,28912%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	59	$19,081
AbbVie	38	$15,509
Pfizer	17	$376
Takeda Pharmaceuticals U.S.A., Inc.	10	$254
Sanofi	5	$159
Bristol Myers Squibb	8	$117
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	5	$111
Aimmune Therapeutics, Inc.	3	$76
Phathom Pharmaceuticals, Inc.	4	$71
Gilead	2	$54
Lilly USA, LLC	2	$53
Intercept Pharmaceuticals, Inc.	3	$50
Ipsen Biopharmaceuticals, Inc	2	$36
Braintree Laboratories, Inc.	2	$36
Regeneron Healthcare Solutions, Inc.	1	$31
Ardelyx, Inc.	1	$22
Madrigal Pharmaceuticals	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Tremfya$18,206
Skyrizi$13,786
STELARA$1,788
Rinvoq$950

How this compares

$36,055 in reported general payments places this provider in the 95th percentile of 447 gastroenterology providers in Washington.

See all gastroenterology providers in Washington →

Medicare billing

Part B allowed, 2024

$177,597

Medicare patients

377

Services billed

4,798

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates	170	$10,634
Mesalamine	33	$9,670
Budesonide EcBudesonide	19	$4,589
Pantoprazole Sodium	151	$2,362
ClenpiqSod Picosulf/Mag Ox/Citric Ac	13	$2,231
Omeprazole	98	$1,588
Dicyclomine Hcl	47	$1,337
Nortriptyline Hcl	45	$601
Nadolol	12	$521
Spironolactone	14	$272
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg	12	$252
Ondansetron OdtOndansetron	11	$249
Ondansetron Hcl	12	$140
Potassium Chloride	13	$88
Furosemide	16	$86

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Seattle

Kris KowdleySeattle$1.4M
Scott LeeSeattle$220K
Alyssa ChoiSeattle$102K
Andrew RossSeattle$99K
Shayan IraniSeattle$57K
Laurens JanssensSeattle$56K
George McDonaldSeattle$53K
Adam TempletonSeattle$49K
Sravanthi ParasaSeattle$47K
Liam HilsonSeattle$37K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →